MET and colorectal carcinoma: The hepatocyte growth factor receptor, HGF R/c-Met, is another fundamental axis in CRC biology, driving proliferation, motility and metastatic invasion through the activation of downstream effectors like RAS/MAPK and PI3K/AKT pathways.